Journal
DIAGNOSTICS
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/diagnostics11030564
Keywords
lipids; proton magnetic resonance spectroscopy; breast cancer
Categories
Funding
- National Center for Research Resources of the National Institutes of Health [S10 RR027926]
- National Cancer Institute of the National Institutes of Health [P30 CA008748]
- Susan G Komen Foundation
- Breast Cancer Research Foundation
Ask authors/readers for more resources
Altered metabolism, including lipid metabolism, is an emerging hallmark of breast cancer. Results of this study showed that breast tumors have significantly lower concentrations of lipid metabolites and PUFA compared to normal fibroglandular tissue. The measure best separating normal and tumor tissues was L21 + L23, indicating the potential of MRS- based lipid measurements in increasing the specificity of breast cancer characterization.
Altered metabolism including lipids is an emerging hallmark of breast cancer. The purpose of this study was to investigate if breast cancers exhibit different magnetic resonance spectroscopy (MRS)-based lipid composition than normal fibroglandular tissue (FGT). MRS spectra, using the stimulated echo acquisition mode sequence, were collected with a 3T scanner from patients with suspicious lesions and contralateral normal tissue. Fat peaks at 1.3 + 1.6 ppm (L13 + L16), 2.1 + 2.3 ppm (L21 + L23), 2.8 ppm (L28), 4.1 + 4.3 ppm (L41 + L43), and 5.2 + 5.3 ppm (L52 + L53) were quantified using LCModel software. The saturation index (SI), number of double bods (NBD), mono and polyunsaturated fatty acids (MUFA and PUFA), and mean chain length (MCL) were also computed. Results showed that mean concentrations of all lipid metabolites and PUFA were significantly lower in tumors compared with that of normal FGT (p <= 0.002 and 0.04, respectively). The measure best separating normal and tumor tissues after adjusting with multivariable analysis was L21 + L23, which yielded an area under the curve of 0.87 (95% CI: 0.75-0.98). Similar results were obtained between HER2 positive versus HER2 negative tumors. Hence, MRS-based lipid measurements may serve as independent variables in a multivariate approach to increase the specificity of breast cancer characterization.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available